Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HMGB2 is a biomarker associated with poor prognosis promoting radioresistance in glioma by targeting base excision repair pathway

10 May 2024

Abstract excerpt

High mobility group box 2 (HMGB2) is considered as a biomarker of poor prognosis in various cancers.This study aims to investigate the effect and mechanism of HMGB2 in gliomas. With the glioma related on-line and our local hospital databases, the expression differences of HMGB2,Kaplan-Meier survival analysis and COX regression analysis were performed.The correlation analysis between the clinicopathological...

Topics

Join the communities discussing this publication.

Advanced Glycation End Products research
Peptidase Inhibition and Analysis
S100 Proteins and Annexins

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38728871
DOI: 10.1016/j.tranon.2024.101977

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HMGB2 is a biomarker associated with poor prognosis promoting radioresistance in glioma by targeting base excision repair pathwayPMID 38728871Read ↗

HMGN2 accelerates the proliferation and cell cycle progression of glioblastoma by regulating CDC20 expressionSemantic proximity Read ↗

HMGA 2 promotes glioma invasion and poor prognosis via a long‐range chromatin interactionSemantic proximity Read ↗

Potential Epigenetic-Based Therapeutic Targets for GliomaSemantic proximity Read ↗

Molecular Characterization of AEBP1 at Transcriptional Level in GliomaSemantic proximity Read ↗

[Advances of glioma biomarkers].Semantic proximity Read ↗

High Expression of H2BC12 Predicts Poor Survival Outcome of Low-Grade Gliomas: A Study Based on TCGA DataSemantic proximity Read ↗

A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in GliomaSemantic proximity Read ↗

In-Depth Summary of Intersected Hub-Genes Between Low-Grade and High-Grade Gliomas, from Bioinformatics and Literature ReportsSemantic proximity Read ↗

Role of HMGB1 and its associated signaling pathways in human malignanciesSemantic proximity Read ↗

Elucidating the Predominant Role of AEBP1 in Different Types of Cancers with a Focus on Glioblastoma Progression – A ReviewSemantic proximity Read ↗

IDH1R132H mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas.Semantic proximity Read ↗

DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.